Clearblow, a Menlo Park, CA-based AI healthcare tech startup, raised a Seed funding of undisclosed amount.
The round was led by Global Venture Capital Partners and angel investor David McCarthy.
The company intends to use the funds to expand its team, establish its product development initiatives, and increase its efforts in commercialization.
Founded in February 2021 by Lach Black, Clearblow is introducing an intelligent pocket spirometer that empowers both adults and children to proactively manage their respiratory health. Spirometry testing plays a pivotal role in tracking lung function, quantifying the volume of air inhaled and exhaled during a single forced breath. The company has designed a Bluetooth-enabled portable device, which translates exhaled air into an acoustic signal. An algorithm extracts spirometric data, analyzes the test results, and generates predictions that contribute to enhanced patient management and outcomes.
The device syncs with a smart app for comprehensive lung health assessment. Beyond measuring FEV1 and PEF data, the app facilitates symptom tracking, medication monitoring, and direct data sharing with the patient’s primary care physician.
FinSMEs
30/10/2023